| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase UNSPECIFIED ION MODE | 230-9609_CON-IL_12.raw | Time:12 | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 231-9852_CON-IL_12.raw | Time:12 | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 232-9610_CON-IL_12.raw | Time:12 | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 233-10336_CON-IL_12.raw | Time:12 | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 234-9855_CON-IL_12.raw | Time:12 | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 235-10218_LPS-IL_12.raw | Time:12 | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 236-8473_LPS-IL_12.raw | Time:12 | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 237-10008_LPS-IL_12.raw | Time:12 | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 238-9785_LPS-IL_12.raw | Time:12 | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 239-10103_LPS-IL_12.raw | Time:12 | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 240-9609_CON-IL_16.raw | Time:16 | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 241-9852_CON-IL_16.raw | Time:16 | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 242-9610_CON-IL_16.raw | Time:16 | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 243-10336_CON-IL_16.raw | Time:16 | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 244-9855_CON-IL_16.raw | Time:16 | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 10336CON-IL-16_NEG.raw | Time:16 | Treatment:CON | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 9609CON-IL-16_NEG.raw | Time:16 | Treatment:CON | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 9610CON-IL-16_NEG.raw | Time:16 | Treatment:CON | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 9852CON-IL-16_NEG.raw | Time:16 | Treatment:CON | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 9855CON-IL-16_NEG.raw | Time:16 | Treatment:CON | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 245-10218_LPS-IL_16.raw | Time:16 | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 246-8473_LPS-IL_16.raw | Time:16 | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 247-10008_LPS-IL_16.raw | Time:16 | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 248-9785_LPS-IL_16.raw | Time:16 | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 249-10103_LPS-IL_16.raw | Time:16 | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 10008LPS-IL-16_NEG.raw | Time:16 | Treatment:LPS | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 10103LPS-IL-16_NEG.raw | Time:16 | Treatment:LPS | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 10218LPS-IL-16_NEG.raw | Time:16 | Treatment:LPS | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 8473LPS-IL-16_NEG.raw | Time:16 | Treatment:LPS | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 9785LPS-IL-16_NEG.raw | Time:16 | Treatment:LPS | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 250-9609_CON-IL_24.raw | Time:24 | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 251-9852_CON-IL_24.raw | Time:24 | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 252-9610_CON-IL_24.raw | Time:24 | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 253-10336_CON-IL_24.raw | Time:24 | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 254-9855_CON-IL_24.raw | Time:24 | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 255-10218_LPS-IL_24.raw | Time:24 | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 256-8473_LPS-IL_24.raw | Time:24 | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 257-10008_LPS-IL_24.raw | Time:24 | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 258-9785_LPS-IL_24.raw | Time:24 | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 259-10103_LPS-IL_24.raw | Time:24 | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 260-9609_CON-IL_48.raw | Time:48 | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 261-9852_CON-IL_48.raw | Time:48 | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 262-9610_CON-IL_48.raw | Time:48 | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 263-10336_CON-IL_48.raw | Time:48 | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 264-9855_CON-IL_48.raw | Time:48 | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 265-10218_LPS-IL_48.raw | Time:48 | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 266-8473_LPS-IL_48.raw | Time:48 | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 267-10008_LPS-IL_48.raw | Time:48 | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 268-9785_LPS-IL_48.raw | Time:48 | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 269-10103_LPS-IL_48.raw | Time:48 | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 210-9609_CON-IL_4.raw | Time:4 | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 211-9852_CON-IL_4.raw | Time:4 | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 212-9610_CON-IL_4.raw | Time:4 | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 213-10336_CON-IL_4.raw | Time:4 | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 214-9855_CON-IL_4.raw | Time:4 | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 215-10218_LPS-IL_4.raw | Time:4 | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 216-8473_LPS-IL_4.raw | Time:4 | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 217-10008_LPS-IL_4.raw | Time:4 | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 218-9785_LPS-IL_4.raw | Time:4 | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 219-10103_LPS-IL_4.raw | Time:4 | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 220-9609_CON-IL_8.raw | Time:8 | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 221-9852_CON-IL_8.raw | Time:8 | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 222-9610_CON-IL_8.raw | Time:8 | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 223-10336_CON-IL_8.raw | Time:8 | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 224-9855_CON-IL_8.raw | Time:8 | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 10336CON-IL-8_NEG.raw | Time:8 | Treatment:CON | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 9609CON-IL-8_NEG.raw | Time:8 | Treatment:CON | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 9610CON-IL-8_NEG.raw | Time:8 | Treatment:CON | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 9852CON-IL-8_NEG.raw | Time:8 | Treatment:CON | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 9855CON-IL-8_NEG.raw | Time:8 | Treatment:CON | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 225-10218_LPS-IL_8.raw | Time:8 | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 226-8473_LPS-IL_8.raw | Time:8 | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 227-10008_LPS-IL_8.raw | Time:8 | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 228-9785_LPS-IL_8.raw | Time:8 | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 229-10103_LPS-IL_8.raw | Time:8 | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 10008LPS-IL-8_NEG.raw | Time:8 | Treatment:LPS | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 10103LPS-IL-8_NEG.raw | Time:8 | Treatment:LPS | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 10218LPS-IL-8_NEG.raw | Time:8 | Treatment:LPS | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 8473LPS-IL-8_NEG.raw | Time:8 | Treatment:LPS | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 9785LPS-IL-8_NEG.raw | Time:8 | Treatment:LPS | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | QC_1_NEG.raw | Time:. | Treatment:. | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | QC_2_NEG.raw | Time:. | Treatment:. | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | QC_3_NEG.raw | Time:. | Treatment:. | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 200-9609_CON-IL_0.raw | Time:- | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 201-9852_CON-IL_0.raw | Time:- | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 202-9610_CON-IL_0.raw | Time:- | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 203-10336_CON-IL_0.raw | Time:- | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 204-9855_CON-IL_0.raw | Time:- | Treatment:CON | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 10336CON-IL-0_NEG.raw | Time:- | Treatment:CON | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 9609CON-IL-0_NEG.raw | Time:- | Treatment:CON | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 9610CON-IL-0_NEG.raw | Time:- | Treatment:CON | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 9852CON-IL-0_NEG.raw | Time:- | Treatment:CON | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 9855CON-IL-0_NEG.raw | Time:- | Treatment:CON | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 205-10218_LPS-IL_0.raw | Time:- | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 206-8473_LPS-IL_0.raw | Time:- | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 207-10008_LPS-IL_0.raw | Time:- | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 208-9785_LPS-IL_0.raw | Time:- | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 209-10103_LPS-IL_0.raw | Time:- | Treatment:LPS | Category:Lipidomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 10008LPS-IL-0_NEG.raw | Time:- | Treatment:LPS | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 10103LPS-IL-0_NEG.raw | Time:- | Treatment:LPS | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 10218LPS-IL-0_NEG.raw | Time:- | Treatment:LPS | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 8473LPS-IL-0_NEG.raw | Time:- | Treatment:LPS | Category:Metabolomics | Normalized ion intensity |
| Reversed phase UNSPECIFIED ION MODE | 9785LPS-IL-0_NEG.raw | Time:- | Treatment:LPS | Category:Metabolomics | Normalized ion intensity |
Return to study ST002063 main page
Download data matrix(Intravenous lipopolysaccharide infusion and the bovine metabolome Reversed phase UNSPECIFIED ION MODE)
- Metabolomics Workbench
|